> Tags > orphan products development

Post about "orphan products development"

FDA Approves Drug for Chorea Treatment in Huntington’s Disease

November 26, 2011 Category :Health Watch 0

Xenazine (tetrabenazine) has been approved by the United States Food and Drug Administration (US FDA) as the first drug for the treatment of chorea among patients with Huntington’s disease. “Xenazine represents hope for patients and families dealing with this difficult disease,” said Dr. Timothy Cote, director of FDA’s Office of Orphan Products Development. “For the first time, there is a treatment that can help patients with this disease gain some quality of life.”

» Continue Reading

Related terms:

, , , ,